BioSight
Companies
Mirum Pharmaceuticals, Inc. logo

MIRM

NASDAQFOSTER CITY, CA
Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals develops and commercializes medicines for rare liver diseases, with approved products already on the market and additional candidates in clinical development. The company focuses on small-molecule drug therapies targeting specific liver conditions where limited treatment options currently exist. Mirum is at a mixed stage, operating as a commercial-stage company with approved medicines while simultaneously advancing earlier-stage product candidates through clinical trials.

Price history not yet available for MIRM.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar